HealthLeaders Media September 29, 2022
Drugmakers, Black Women’s Health Imperative press for diversity in the healthcare system.
– Pharmaceutical companies are partnering to increase participation in clinical trials.
– The solution to health equity lies in changing health infrastructures.
– Without consequences or incentives, health stakeholders will not transform their behavior toward patients of color.
According to FDA data, in 2020 more than 32,000 people took part in drug trials and 75% were white, 11% were Hispanic, 8% were Black, and 6% were Asian. The aftermath of COVID-19 shed light on glaring health disparities in the system, as access to vaccines and care impacted ethnic minority groups unequally.
In reaction to this spotlight, several pharma companies have pledged to increase their efforts in narrowing...